WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 596249
Description: Bavisant dihydrochloride is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD. Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity. Research indicates that H3 receptor antagonists due to their novel mechanism of action may have a unique treatment effect offering an important alternative for the treatment of ADHD.
MedKoo Cat#: 596249
Name: Bavisant dihydrochloride
Chemical Formula: C19H31Cl2N3O3
Exact Mass: 419.1742
Molecular Weight: 420.37
Elemental Analysis: C, 54.29; H, 7.43; Cl, 16.87; N, 10.00; O, 11.42
Synonym: Bavisant dihydrochloride; JNJ-31001074-AAC; JNJ 31001074-AAC; JNJ31001074-AAC;
IUPAC/Chemical Name: (4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone dihydrochloride hydrate
InChi Key: BLFBQJUVAGIUBL-UHFFFAOYSA-N
InChi Code: InChI=1S/C19H27N3O2.2ClH.H2O/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20;;;/h1-4,18H,5-15H2;2*1H;1H2
SMILES Code: O=C(N1CCN(C2CC2)CC1)C3=CC=C(CN4CCOCC4)C=C3.[H]Cl.[H]Cl.[H]O[H]
1: Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000. PubMed PMID: 22519922.